» Articles » PMID: 33181857

Electrolyte Disorders in Stable Renal Allograft Recipients

Overview
Journal Swiss Med Wkly
Specialty General Medicine
Date 2020 Nov 12
PMID 33181857
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Acid base and electrolyte disorders are frequently reported in the early period after renal transplantation. No comprehensive data exist on the prevalence and patterns of, and contributing factors to, electrolyte disturbances in patients with stable long-term allograft function.

Methods: We analysed 576 renal transplant recipients (serum creatinine level <2.0 mg/dl) in a cross-sectional study to evaluate the prevalence of electrolyte disorders and the risk factors associated with their occurrence.

Results: A total of 369 patients (64%) of all allograft recipients (n = 576) showed at least one electrolyte and acid base disorder. The most abundant disorder was hypomagnesaemia (25%, n = 143), followed by hyperkalaemia (12.8%, n = 74), hypercalcaemia (12%, n = 69), hypophosphataemia (11.6%, n = 67), metabolic acidosis (11.1%, n = 61) and hyponatraemia (9%, n = 52). All other electrolyte disorders were rare (<6%). In most cases the electrolyte disorders could be classified as mild. Forty percent of the cases had a combined disorder, but without a preferential pattern of combinations. In a multivariate logistic regression analysis, the most important factors contributing significantly to the occurrence of electrolyte disorders were renal function and concomitant medications.

Conclusion: Acid base and electrolyte disorders are frequently observed in stable renal allograft recipients, but are usually mild. A combination of two or more electrolyte abnormalities often occurs, although no predominant pattern of a unique combination of electrolyte disorder is recognizable. &nbsp.

Citing Articles

Immunosuppressive therapy and nutritional diseases of patients after kidney transplantation: a systematic review.

Kajdas A, Kleibert M, Normann A, Krasuski K, Sondergaard Linde D, Szostak-Wegierek D BMC Nephrol. 2025; 26(1):33.

PMID: 39838284 PMC: 11748333. DOI: 10.1186/s12882-025-03964-0.


Novel Drugs for the Management of Diabetes Kidney Transplant Patients: A Literature Review.

Valencia-Morales N, Rodriguez-Cubillo B, Loayza-Lopez R, Moreno de la Higuera M, Sanchez-Fructuoso A Life (Basel). 2023; 13(6).

PMID: 37374048 PMC: 10304316. DOI: 10.3390/life13061265.


Sodium-glucose cotransporter-2 inhibitor therapy in kidney transplant patients with type 2 or post-transplant diabetes: an observational multicentre study.

Sanchez Fructuoso A, Bedia Raba A, Banegas Deras E, Vigara Sanchez L, Valero San Cecilio R, Franco Esteve A Clin Kidney J. 2023; 16(6):1022-1034.

PMID: 37260993 PMC: 10229265. DOI: 10.1093/ckj/sfad007.


Impact of Hyponatremia after Renal Transplantation on Decline of Renal Function, Graft Loss and Patient Survival: A Prospective Cohort Study.

Berchtold L, Filzer A, Achermann R, Devetzis V, Dahdal S, Bonani M Nutrients. 2021; 13(9).

PMID: 34578871 PMC: 8468476. DOI: 10.3390/nu13092995.